The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


News Update

Biotech Achieves Development Milestone for Blue Light Imaging System

News Update
  ()
The surgical imaging firm continues to advance its first medical device toward commercialization. read more >
News Update

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies

News Update
  ()
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. read more >
News Update

Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States

News Update
  ()
With this development, the Canadian company further expands its U.S. footprint. read more >

Premier Health Group Adding Medical Cannabis Support Tool

  ()
This clinical decision support software integration is the first of its kind, according to the company. read more >

5 Small-Caps on Fund Manager Steve Palmer's Radar Screen

  ()
Steve Palmer, Founding Partner, President and Chief Investment Officer for AlphaNorth Asset Management, talks about a handful of companies in diverse industries that have his attention. read more >

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

Research Report
  ()
A Ladenburg Thalmann report reviewed the study design and purpose. read more >

Anixa Doesn't Disappoint

Contributed Opinion
  ()
Daniel Carlson of Tailwinds Research explains why he has designated this company his 2019 stock of the year. read more >

Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic

Research Report
  ()
The background and justification for the deal was covered in an H.C. Wainwright & Co. report. read more >

Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate'

Research Report
  ()
A William Blair report reviewed the firm's operational and financial numbers for the period. read more >

Health Stock 'Looking Set to Bounce Back After 90% Drop'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. read more >
Showing Results: 1 to 10 of 10

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"Adding some possible blue sky to the GSV story is drilling at Lewis."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"LIO announced aggressive plans to explore its consolidated property."
– Derek Macpherson, Red Cloud Klondike Strike Inc.
"AVU's Sesmarias could be an extension of the ore body at Lousal."
– Siddharth Rajeev, Fundamental Research Corp.
"This is a good time to buy TEN; we stay long."
– Clive Maund, CliveMaund.com